Canaccord Genuity analyst William Plovanic downgrades Shockwave Medical (NASDAQ:SWAV) from Buy to Hold and raises the price target from $263 to $335.
Canaccord Genuity Downgrades Shockwave Medical to Hold, Raises Price Target to $335
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.